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Antigen array for serological 
diagnosis and novel allergen 
identification in severe equine 
asthma
S. J. White  1,2,3*, M. Moore-Colyer1, E. Marti4, D. Hannant  5, V. Gerber4, L. coüetil  6, 
e. A. Richard  7,8 & M. Alcocer2
Severe equine asthma (sEA), which closely resembles human asthma, is a debilitating and performance-
limiting allergic respiratory disorder which affects 14% of horses in the Northern Hemisphere and is 
associated with increased allergen-specific immunoglobulin E (IgE) against a range of environmental 
proteins. A comprehensive microarray platform was developed to enable the simultaneous detection 
of allergen-specific equine IgE in serum against a wide range of putative allergenic proteins. The 
microarray revealed a plethora of novel pollen, bacteria, mould and arthropod proteins significant in 
the aetiology of sEA. Moreover, the analyses revealed an association between sEA-affected horses and 
IgE antibodies specific for proteins derived from latex, which has traditionally been ubiquitous to the 
horse’s environment in the form of riding surfaces and race tracks. Further work is required to establish 
the involvement of latex proteins in sEA as a potential risk factor. This work demonstrates a novel and 
rapid approach to sEA diagnosis, providing a platform for tailored management and the development of 
allergen-specific immunotherapy.
Severe equine asthma (sEA) is a performance limiting, debilitating condition which is prevalent in 14% of horses 
in the Northern Hemisphere1. The pathogenesis of this condition remains controversial with many contradic-
tory reports2,3; but several studies have indicated the role of immunoglobulin E (IgE) through in vitro histamine 
release assays4–6, and allergen-specific IgE (sIgE) analyses of bronchoalveolar lavage fluid (BALF) and sera5,7,8. 
Specific IgE assays suggest that Aspergillus fumigatus (Asp f (extract), rAsp f 8, Asp f 1/a), Alternaria alternate, 
Tyrophagus putrescentiae, Saccharopolyspora rectivirgula, Aspergillus terreus, Eurotium amstelodami, Geotrichum 
candidum and Wallemia sebi may be implicated in the aetiology of sEA2,3,8–11. More recently, White et al., (2017) 
identified 40 potential allergens of interest, from several genera, including fungi, bacteria, pollen and arthropod12.
sEA diagnosis is presently conducted on clinical history and readily identified clinical signs13, which have 
been shown to correlate with sEA severity14, with ancillary diagnostic tests such as BALF cytology, lung function 
testing, haematology, and immunological testing used to improve diagnostic accuracy15. While several studies 
have addressed the potential benefits derived from in vitro allergen assessment in diagnosis of sEA, commercial 
application has been hampered due to a lack of statistical approaches for clear disease classification, and the lim-
ited range of allergens tested to date.
More recently, White et al., (2019) developed microarray methods to enable IgE profiling in sEA-affected 
horses, elucidating previously unidentified causal allergens and demonstrating a strong correlation between 
BALF and sera specific IgE profiles16. The aim of the present study was to use sera from a large group of horses 
from France, Switzerland, USA and Canada, exposed to a wide range of potential allergens in the normal equine 
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environment and determine if a combination of microarray and mathematical modelling could be used to elu-
cidate previously unidentified allergens involved in the aetiology of sEA, as a potential diagnostic test for sEA, 
and to evaluate the influence of samples from mixed environments without matched controls. To achieve this, we 
primarily used specific allergen molecules, thus identifying genuine sensitisation and minimising cross-reactivity, 
potentially enabling precise allergen selection for future immunotherapy.
Materials and Methods
Equine sera samples. Horses from Canada, France and the US were classified according to clinical assess-
ment, including physical examination, tracheal mucus, pulmonary function test, reversible airway obstruction 
after medical/environmental change and BALF cytology, demonstrating moderate to severe neutrophilia (>25% 
cells), as previously described15. Control horses had no record of lung disease, no previous history of laboured 
breathing, coughing or nasal discharge, no tracheal mucus, and <10% BALF neutrophils. Swiss samples were 
those published in Verdon et al.17, sEA was classified using the horse owner assessed respiratory signs index 
(HOARSI) ≥3 and partial pressure of arterial oxygen <90 mm Hg, and Insect Bite Hypersensitivity (IBH) clas-
sified via IBH scoring17. Blood was collected from the jugular vein in VACUETTE Serum Clot Activator Tubes, 
centrifuged at 2000 × g for 10 minutes, serum removed and stored at −80 °C. This study was approved by the 
Royal Agricultural University Ethical Review Group. All experiments were performed in accordance with the 
relevant guidelines and regulations.
In the first part of the study, a sub-group of the total of 138 sports horses, consisting of n = 35 environmentally 
matched samples from France (5 sEA; 6 control), USA (6 sEA; 6 control) and Canada (6 sEA; 6 control) were 
analysed. These were modelled to enable reliable comparison of samples with matched controls collected from 
horses in the same environment, thus accounting for any antigenic stimuli associated IgE responses. In order to 
test the robustness and clinical relevance of the test, in the second phase of the study, microarray analysis was 
carried out on a larger group, including the aforementioned horses and those from differing environments with-
out matched controls (n = 138), consisting of sEA n = 33, IBH/sEA n = 23, IBH n = 24 and control n = 58 from 
France, Switzerland, USA and Canada. Horses suffering with IBH, a classic equine hypersensitivity, were included 
to further assess the discriminatory power and clinical relevance of this approach. This group (n = 138) was used 
to build and test the mathematical predictive model and identify relevant allergens.
IgE sera determination by protein microarray. The comprehensive complex microarray comprised of 
extracts (n = 153) and pure proteins (n = 231) from a wide range of fungi, bacteria, pollen, arthropods and others 
associated with the equine environment. The extracts and pure proteins were obtained from commercial sup-
pliers, produced in-house and donated to our group. Fungi and bacteria strains were purchased from Deutsche 
Sammlung von Mikroorganismen und Zellkulturen, grown in liquid media, and extracts produced via sonication. 
Samples were normalised to 0.5 mg/ml protein and printed onto ONCYTE® NOVA Nitrocellulose Film Slides 
(Grace Bio-Labs, Oregon, USA) using an Ultra Marathon II by Arrayjet, (Roslin, Scotland) to a final spot density 
of 12,288 spots/slide, with an approximate spot size of 200 μm diameter and replicated twice into two blocks on 
each pad. For alignment purposes Cy3/Cy5 were included, and for quality control purposes a number of sham 
antigens were spotted (e.g. PBS, Equ c 3, Ara h 1-NT, Man e, Gal d 1–4). Slides were blocked in 3% BSA (w/v) 
in PBS inside a Corning 5 slide holder (product # 40082) using a mini hybridization oven (Appligene, USA) at 
37 °C for 3 h, washed three times for 2 min in PBS containing 0.05% (w/v) Tween-20, followed by five times 1 min 
washes with Milli-Q water, and dried via centrifugation (MSE Mistral 3000i, Sanyo, UK) 300 × g for 10 min at 
room temperature.
Slides were fitted with Proplate slide modules (Grace Bio-Labs, product # 204862) and washed three times 
(60 second dwell time) with PBST (0.2%). Sera samples were diluted 1:2 with 4% BSA in 0.4% PBST, and 100 μl 
of prepared sample was added to each well, excluding well 4, which was a control filled with 100 μl of the dilution 
solution (1:2) in 2% BSA in 0.2% PBST (final dilution). The Proplate was fitted with an adhesive seal strip and 
incubated for 16 hours at 4 °C on the Stuart mini see-saw rocker (SSM4) at 13 oscillations/minute. Slides were 
washed three times with PBST (0.05%) using the BioTek plate washer and incubated for 2 hours at 37 °C in a 
ThermoHybaid (HyPro 20) at AVS 3 with 100 μl per well of anti-horse IgE (BioRad, #MCA5982GA) 1:400 in 1% 
BSA in 0.2% PBST. They were washed a further 3 times with PBST (0.05%) and incubated for one hour at 37 °C in 
the ThermoHybaid with 100 μl per well of DyLight 649 conjugated anti-mouse IgG (Rockland, Product #610-443-
040) 1:400 in 1% BSA in 0.2% PBST. Slides were then washed three times with PBST (0.05%) followed by three 
washes with Milli-Q water and dried via centrifugation at 300 × g for 10 mins (Mistral 3000i, rotor 43124-708).
Data analysis. Processed slides were scanned in a GenePix 4000B (Molecular Devices, USA) with the PMT 
settings 440 and 310 at 635 and 532 nm and saved as TIF files. Images were processed in GenePix Pro software 
v6.0.1.27 (Axon Instruments) and saved as comma-delimited text files. Digital fluorescence units (DFUs) were 
calculated for each spot by subtracting local background from the median fluorescence value of the spot. One pad 
on each microarray was used as a control, containing reagents and no serum, the results of which were subtracted 
from all other pads to account for any auto-fluorescence or non-specific binding. Clinically healthy and IBH 
horses were used as control.
PLS toolbox (version 5.8.3, Eigenvector Research Inc., USA) running on a MATLAB platform (MathWorks, 
Cambridge, UK) was used to carry out principal component analysis and partial least squares discriminant anal-
ysis (PLS-DA) was used as a classifier which enabled construction of the predictive mathematical models7. Partial 
Least Squares Discriminant Analysis (PLS-DA), a type of PLS regression against a dummy matrix, was used to 
separate pre-defined classes of samples (i.e. affected/non-affected horses). The model was used to inform which 
specific variables (allergens) are important to determine class prediction18. A variable influence on the projection 
(VIP) score of each variable was calculated as a weighted sum of the squared correlations between the original 
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variable and the PLS-DA components. This is a measure of the contribution that a specific variable has on the 
model19. In order to test the mathematical model produced, multiple rounds of cross validation (CV) were per-
formed using different partitions, and the validation results were amalgamated through the rounds giving an 
estimate of the model’s predictive performance19.
Results
Environmentally matched group. The initial calibration of the PLS-DA classification method using the 
small subset of environmentally matched samples (n = 35) was highly encouraging, with CV values confirming 
good prediction (Table 1). In an effort to reduce the background noise and improve robustness of the mathemati-
cal model, a second round of modelling was conducted using the main VIPs (n = 129) identified in the calibration 
step (Fig. 1). This improved both sensitivity and specificity of the (CV) mathematical model (Table 1).
Environmentally mixed group. The mathematical calibration model with the reduced number of sEA 
horses and matched samples has shown that it is feasible to discriminate sEA from control animals. Whether 
other allergic diseases and samples without matched controls would interfere with the detection and classification 
method has been tested using a cohort of 138 horses (34 sEA, 23 IBH/EA, 23 IBH and 58 controls). The PLS-DA 
calibration modelling involving this new cohort (n = 138) confirmed the good prediction for sEA obtained with 
non-matched samples, particularly after the second round of mathematical modelling using the sEA VIP selec-
tion (Table 2). A wide range of VIPs were identified as significant for class prediction (see Supplementary Data), 
predominant variables included Hev b 11, Hev b 6.02, Hev b 5.0101, rAsp f 8 and Hel as 7.
Before VIP selection After VIP selection
CAL CV CAL CV
Specificity 1.00 0.70 1.00 1.00
Sensitivity
Error
1.00
RMSEC = 0.092
0.72
RMSECV = 0.480
1.00
RMSEC = 0.052
0.94
RMSECV = 0.275
Table 1. Partial least squares discriminant analysis statistics of the calibrated and cross validated data from the 
environmentally matched group of horses (n = 35) from the first (before VIP selection) and second (after VIP 
selection) rounds of modelling. CAL = calibration; CV = cross validation.
Figure 1. Variable influences on the projection calculated by PLS-DA software from the environmentally 
matched group of horses (n = 35) after VIP selection. A threshold of α > 1 was used to identify those VIPs 
significant in class prediction.
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Discussion
Previously, using Partial Least Squares Regression we demonstrated that human IgE microarray analysis with 
extracts and pure proteins correlate well with standard laboratory methods such as ELISA, UniCAP and immu-
noblot test20. Similarly, there was good agreement between equine IgE microarray and ELISA results in this study 
(see Supplementary Data). Mathmatical modelling of profiling data for disease classification and allergen iden-
tification is well utilised in human alogology, but has had little application in the veterinary sector7. Based on 
these principles, we utilised latest technological developments and mathematical modelling to explore sEA. This 
enabled the widest scale sEA-associated allergen profiling to date. This study utilised whole protein extracts to 
maximise allergen coverage, while maintaining specificity by including purified proteins where allergens were 
known. This was essential because of the limited numbers of potential sEA allergens screened by others to date. 
Further work would benefit from purifying proteins of the identified whole extracts of interest, thus providing 
well-defined reagents for component resolved diagnostics enabling increased specificity and sensitivity, particu-
larly aimed at the use of specific immunotherapy21.
Many of the allergens identified in the initial model (Fig. 1) have previously been implicated in human aller-
gic asthma, but not previously assessed in the horse. Erwinia, Geotrichum candidum and Eurotium amstelodami 
have been associated with asthma and occupational respiratory diseases in farmers9,22–24. Moreover, Junioerus 
virginiana and Corylus avellane pollen are often noted as inciting hay fever and asthma25. Particularly noteworthy 
allergens include Aspergillus versicolor, A niger and A fumigatus all from the most significant genus associated 
with the aetiology of human asthma and sEA24. Similarly, Dermatophagoides farinae is associated with human 
asthma as well as sEA11,26, and Pen i 1 is cross-reactive to many arthropods27. Furthermore, several latex allergens 
are significant for class prediction, a group previously untested in the horse.
The classification results (CV sensitivity and specificity) from the second model (Fig. 2) were however lower 
than the first small subset of horses. The discrepancies between the two subgroups most likely results from the 
second group being collected from varying environments as described by Eder et al.8. These authors assessed 
450 horses from 6 different yards and concluded stable-specific environments have a highly significant effect on 
sEA Control IBH
CAL CV CAL CV CAL CV
Specificity 0.865 0.865 0.787 0.725 0.957 0.902
Sensitivity 0.765 0.735 0.931 0.81 0.826 0.674
Error RMSEC = 0.315 RMSECV = 0.360 RMSEC = 0.366 RMSECV = 0.413 RMSEC = 0.108 RMSECV = 0.366
Table 2. Partial least squares discriminant analysis statistics of the calibrated and cross validated data from the 
environmentally mixed group of horses (n = 138) showing different classification values after sEA VIP selection. 
CAL = calibration; CV = cross validation.
Figure 2. Variable influences on the projection (VIP) scores calculated by PLS-DA from the environmentally 
mixed group of horses (n = 138) after VIP selection. A threshold of α > 1 was used to identify those VIPs 
significant in class prediction.
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allergen-specific serum IgE levels. The second group presented here did not have matched controls to account for 
environmental-associated IgE production and possessed a strong IBH response bias which may have weakened 
the mathematical predictive model. The most influential VIPs for class separation were those from natural rub-
ber latex (Hevea brasiliensis, Hev b), these included Hev b 11; Hev b 6.02; Hev b 5.0101; Hev b 3.0101 and Hev 
b-extract (see Supplementary Data). To the authors knowledge, this is the first time Hev b allergens have been 
assessed in relation to sEA. As shown in Fig. 2, a smaller level of IgE-binding to latex allergens was detected in the 
sera of IBH positive horses and controls used in this study (latex means: 1445, 735, 803 for sEA, IBH and control 
respectively with P < 0.0001 when compared to sEA), however latex allergens alone were not able to discrimi-
nate the sEA group. As shown in Table 2 this discrimination is much improved with the other VIPs, particularly 
Aspergillus (Asp f 8).
Work in human asthma patients has revealed a higher frequency of Hev b allergies in affected individuals28. A 
major source of respirable Hev b allergens in the horse’s environment is from artificial riding surfaces. Although 
the use of recycled tyres was banned in many parts of Europe in 2007, in the UK it is permitted under current 
Environment Agency waste regulations (Waste Exemption: U8 use of waste for a specified purpose), and many 
arena surfaces throughout the world contain components of natural rubber. These surfaces have high levels of res-
pirable dust, which has previously been associated with chronic bronchitis in riding instructors29–31. Respiration 
of Hev b particles have also been shown to induce inflammation and oxidative stress in the lungs of humans32. 
Furthermore, particles, such as Hev b, have been shown to exhibit an adjuvant effect by increasing the primary 
response during sensitisation when present either before, during or after allergen exposure33. Diaz-Sanchez et al., 
(1999) demonstrated particulate inhalation during allergen exposure could induce a mucosal IgE response under 
conditions in which the allergen alone could not34. Similarly, experimental animal models in strains of mice not 
prone to developing IgE responses, demonstrated that particulate antigens may enhance sensitisation35. Given 
the adjuvant and sensitising effects of latex, these airborne particles could contribute to the increase in both latex 
sensitisation and asthma through direct and indirect mechanisms36,37, which may explain the association between 
sEA and Hev b-specific IgE demonstrated here. Moreover, these results are in agreement with previous work 
identifying the urban environment, which is high in respirable natural rubber latex37, as a risk factor in sEA38. In 
humans, regular exposure to latex particles in the work environment can lead to occupational asthma, commonly 
known as latex-induced asthma. The prevalence of latex sensitisation in occupationally-unexposed groups is sig-
nificantly lower (<1%) than those regularly exposed (>18%)39. The main allergen associated with occupational 
latex-allergy (Hev b 6.02)40 was the second most influential VIP in our study group with sEA-affected horses, 
along with other major Hev b-allergens used for occupational latex-allergy diagnosis (Hev b 11; Hev b 5.0101)41. 
The results of this study would suggest there may be an association between sEA and increased latex-specific IgE. 
Further equine specific work is required to establish the exposure levels of latex in the horse’s daily environment, 
demonstrating the benefit of latex avoidance, latex inhalation reactivity tests, epidemiological studies and further 
hypersensitivity confirmation through basophil activation tests. At present, exposure should be considered a 
potential risk to the respiratory health of the horse.
Several fungal allergens were found to significantly influence class prediction, these included Aspergillus 
fumigatus (rAsp f 8), Mucor circinelloides f. lusitanicus (Muc ci), Geotrichum candidum (Geo c) and Eurotium 
amstelodami (Eur a) (see Supplementary Data). The rAsp f 8 results confirm those of Eder et al., (2000) and 
Künzle et al., (2007) whom also found significantly more IgE against this recombinant mould allergen in 
sEA-affected horses8,10. Tahon et al., (2009) also reported significantly higher positive intradermal reactions to 
rAsp f 8 in sEA-affected horses42. Mucor circinelloides f. lusitanicus (Muc ci) results further confirm previous 
research demonstrating Mucor allergen extract sensitisation is associated with sEA-affected horses via in vitro 
basophil assay5. Similarly, increased levels of specific IgE against E. amstelodami and G. candidum have been 
identified in the bronchoalveolar lavage fluid of sEA affected horses via western blot9. Several arthropods were 
significant for class separation, including the tropomyosin’s of Helix aspersa (Hel as 7 and Periplaneta Americana 
(Per a 7), the proteases from Blattella germanica (Bla g 2) and Dermatophagoides farinae (Der f 1), the complex 
mixture of Blomia Tropicalis (Blo t), and Dermatophagoides pteronyssinus (Der p 2). The array results therefore 
ratify recent reports on the involvement of Acarus siro, Dermatophagoides, farinae/pteronyssinus, Tyrophagus 
putrescentia in sEA and their association with high concentrations of specific IgE against mites, particularly T 
putrescentia11. Bla g 2 is associated with the development of asthma in humans and increased sIgE against Bla 
g has previously been reported in sEA-affected horses16,43. Tropomyosin results (Hel as 1 and Per a 7) are to be 
expected, as Tropomyosin are major allergenic components accounting for cross-reactivity with mites and other 
arthropods44. Furthermore, the high VIP scores demonstrated for Cullicoides proteins (Cul nu 2, CO145, Cul o 
2) could have resulted from the sEA/IBH horses, even though these were matched with IBH controls, or from 
multiple hypersensitivities, as sEA horses are at increased risk of IBH45 which is associated with airway hyperre-
activity46. The only bacteria considered significant for class separation was Thermoactinomyces vulgaris, which has 
long been associated with sEA and increased levels of IgE in affected horses47–49. Interestingly, our study showed 
28 pollens were significant for class separation, including Betula verrucosa (Bet v 2.0101), Mercurialis annua 
(Mer a 1), Eupatorium capillifolium (Eup c), Quercus robur (Que r) and Helianthus annuus (Hel a). To the authors 
knowledge, this is the first study to show an association between sEA in horses and a hypersensitivity to pollens. 
When utilising a panel of 131 allergens, Einhorn et al., (2018) demonstrated that horses are most likely to be sen-
sitised to Fag e 2, Cyn d 1 and Aln g 1, similarly here we found Fag e was significant for class prediction (Fig. 2)50.
As expected, the environmentally matched (MA) group has several VIPs in common with the environmen-
tally mixed (MI) group. Most notably Hev b 11, Hev b 6.02, rAsp f 8, Eur s and Hev b 5.0101. Moreover, many 
similarities are apparent, such as Der f and tropomyosin Pen i 1 in MA compared with Der f 1 and tropomyo-
sin Hel as 7 in MA. The MI group was equally reliant on a range of aspergillus species (Asp v, Asp n, rAsp f 8), 
whereas the MA group primarily relied on rAsp f 8. Bovine milk proteins are important for class prediction in 
both models (MA - Bos d 4, Bos d 9; MI - Bos d LF), the significance of this warrants further research, these 
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molecules commonly cross react between species and have shared common allergenic components with other 
allergens, such as Glycine max51.
Use of a PLS-DA model enabled the classification of sEA-affected horses using IgE as a biomarker, which has 
previously not been possible with the utilised statistical methods due to overlap between affected and non-affected 
groups8,50. Such models have been employed in the human sector to enable diagnosis of asthma patients using 
metabolomics with great success, and proved to be just as effective with sEA2,7,19. Furthermore, the identification 
of specific IgE auto-reactivity through VIP identification contributes to an understanding of the pathogenesis of 
the disease. The ability to discriminate sEA-affected horses from other IgE-mediated conditions demonstrates the 
robustness of the test. Further research expanding the repertoire of allergens tested in the form of pure proteins 
would increase the diagnostic accuracy of the mathematical model as well as benefiting identification of genuine 
sensitisation and enabling therapeutic and diagnostic development. This advanced bioinformatics enabled the 
largest scale allergen profiling of sEA to date, significantly contributing to aetiological understanding of this 
complex disease.
In conclusion, the microarray platform demonstrated here may be utilised as axillary diagnosis for sEA, 
informing accurate allergen-avoidance regimes based on its sensitisation profiles; while simultaneously elucidat-
ing important factors associated with the aetiology and pathogenesis of this complex disease. Moreover, it enables 
further diagnostic developments and the creation of specific immunotherapy treatments. This serological inves-
tigation of 138 horses living in varying environments identified that sEA is associated with a large sensitisation 
profile, and predominantly involves latex, fungi, mite and pollen proteins; demonstrating similar profiles to that 
found with allergic asthma in the human. These results indicate that exposure to latex may be detrimental to the 
respiratory health of the horse. Further research is required to establish the levels of latex exposure in the equine 
environment and its in vivo effects. Sensitivity and specificity values confirmed the high discriminatory power 
of the technique in combination with mathematical modelling. The microarray platform demonstrated here will 
enhance the health, welfare and performance of sEA affected horses. This has been achieved on a number of levels 
through (a) the development of a novel serological diagnostic test, (b) improved understanding of disease patho-
genesis, and (c) identification of novel allergenic candidates.
Data availability
The datasets generated and/or analysed during the current study are available from the corresponding author on 
reasonable request.
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